Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 28 August 2026.
Announcements
6,191
Total raised
£161B
disclosed amounts
This month
£621M
raised so far
The funding will enable Bio-Images Drug Delivery to expand its manufacturing capacity and grow its team across two sites.
"OralogiK is a truly exciting technology that could transform the lives of many patients and this funding will accelerate its route to market. More than that, by partnering with Archangels, BDD can access its network of sector experts and ensure that we can fully capitalise on the potential of OralogiK"
The funding round was led by Chairman Ashley Cooper and will support the company in scaling its innovation platforms.
"We are now in a world where it is crucial to have a creative and innovative mindset. Our technology is unlocking the entrepreneurial behaviours of individuals, organisations and communities by digitally bringing people together. This opens up access to previously untapped resources, ideas and solutions while seamlessly bridging the gap between industry and academia."
True Ventures led the seed financing round with participation from Accelerated Digital Ventures and notable angel investors.
"We believe farmers are often the best and most relevant source of information and experience for other farmers,"
BGF Ventures led the seed financing for Streetbees to support team expansion and platform development.
"In a world where brands are willing to invest huge amounts of resources to better understand their consumers, there has to be a better way to capture insights and Streetbees has found it. We use geolocation and mobile technology to engage the right person in the right place to answer brands' questions. Streetbees' grassroots research approach is providing the brands with the rich consumer insights they need at large scale at an affordable price as we connect them directly with their consumers without any intermediaries."
Astia Angels and Wheatsheaf Group have backed the genomic analytics firm in its latest funding round.
"We have developed innovative analytics and AI capabilities that enable a new generation of precision medicine and precision agriculture solutions. The ability to deliver combinatorial, multi-omic analysis at scale is a critical missing piece in realising the benefits of the genomics, IOT and AI revolutions. This investment will enable us to scale our business to address the significant global opportunities in these high-growth markets."
